A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France
Clinical trial NCT03757013 · COMPLETED
Trial details
- NCT number
- NCT03757013
- Sponsor
- Amgen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-25
- Primary completion
- 2021-07-21
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.